Shraman Vardhaman Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 K
- Company Age 33 Year, 10 Months
- Open Charges ₹ 3.00 M
About Shraman Vardhaman Pharmaceuticals
Shraman Vardhaman Pharmaceuticals Private Limited (SVPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 April 1991 and has a history of 33 years and ten months. Its registered office is in Chennai, Tamil Nadu.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 K .
The company currently has active open charges totaling ₹3.00 M.
Company Details
- Location Chennai, Tamil Nadu
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24294TN1991PTC020694
- Company No.
020694
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 1991
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Shraman Vardhaman Pharmaceuticals?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Shraman Vardhaman Pharmaceuticals.
Enhance accessibility to Shraman Vardhaman Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shraman Vardhaman Pharmaceuticals?
Unlock access to Shraman Vardhaman Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jul 1996 | Union Bank Of India | ₹0.25 M | Open |
| 13 Jul 1994 | Union Bank Of India | ₹1.25 M | Open |
| 20 Jun 1994 | Union Bank Of India | ₹1.00 M | Open |
| 22 Oct 1993 | Union Bank Of India | ₹0.50 M | Open |
How Many Employees Work at Shraman Vardhaman Pharmaceuticals?
Unlock and access historical data on people associated with Shraman Vardhaman Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shraman Vardhaman Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shraman Vardhaman Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.